Omeros (OMER) Change in Acquisitions & Divestments (2010 - 2026)
Omeros (OMER) posted Change in Acquisitions & Divestments of $30.0 million for Q1 2026, down 21.74% sequentially from $38.4 million in Q4 2025, and down 23.54% YoY from $39.3 million in Q1 2025.
Analysis
Omeros (OMER) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends
Omeros has reported Change in Acquisitions & Divestments for 17 years, with the latest figure at $30.0 million in Q1 2026.
- Quarterly Change in Acquisitions & Divestments fell 23.54% year-over-year to $30.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $100.6 million (down 85.27% YoY) and the FY2025 annual result came in at $109.9 million, down 89.73% from the prior year.
- Change in Acquisitions & Divestments fell to $30.0 million in Q1 2026 per OMER's latest filing, from $38.4 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $425.7 million in Q1 2024 and troughed at $6.2 million in Q1 2022.
- A 5-year average of $150.5 million and a median of $100.5 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
- The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments soared 5425.97% in 2023, then sank 96.84% in 2025.
- Over 5 years, Change in Acquisitions & Divestments stood at $217.0 million in 2022, then jumped by 36.12% to $295.4 million in 2023, then tumbled by 65.96% to $100.5 million in 2024, then sank by 61.81% to $38.4 million in 2025, then dropped by 21.74% to $30.0 million in 2026.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $30.0 million, $38.4 million, and $10.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Omeros | 1.38 Bn | 1.38 Bn | 27.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.60 Mn |
| Mar 31, 2026 | 30.05 Mn |
| Dec 31, 2025 | 38.40 Mn |
| Sep 30, 2025 | 10.50 Mn |
| Jun 30, 2025 | 21.70 Mn |
| Mar 31, 2025 | 39.30 Mn |
| Dec 31, 2024 | 100.55 Mn |
| Sep 30, 2024 | 331.81 Mn |
| Jun 30, 2024 | 211.73 Mn |
| Mar 31, 2024 | 425.69 Mn |
| Dec 31, 2023 | 295.37 Mn |
| Sep 30, 2023 | 234.06 Mn |
| Jun 30, 2023 | 174.45 Mn |
| Mar 31, 2023 | 342.61 Mn |
| Dec 31, 2022 | 216.99 Mn |
| Sep 30, 2022 | 33.40 Mn |
| Jun 30, 2022 | 45.00 Mn |
| Mar 31, 2022 | 6.20 Mn |
| Dec 31, 2021 | 18.50 Mn |
| Sep 30, 2021 | 18.00 Mn |